Human Genetics

, Volume 66, Issue 1, pp 17–40 | Cite as

Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention

  • H. Moser
Review Articles

Summary

Duchenne muscular dystrophy (DMD) is the most common sex linked lethal disease in man (one case in about 4000 male live births). The patients are wheelchair bound around the age of 8–10 years and usually die before the age of 20 years. The mutation rate, estimated by different methods and from different population studies, is in the order of 7×10-5, which is higher than for any other X-linked genetic disease. Moreover, unlike other X linked diseases such as hemophilia A or Lesh-Nyhan's disease, there seems to be no sex difference for the mutation rates in DMD. Several observations of DMD in girls bearing X-autosomal translocations and linkage studies on two X chromosomal DNA restriction fragment length polymorphisms indicate that the DMD locus is situated on the short arm of the X chromosome, between Xp11 and Xp22. It may be of considerable length, and perthaps consisting of actively coding and non-active intervening DNA sequences. Thus unequal crossing over during meiosis in females could theoretically account for a considerable proportion of new mutations.

However, there is no structurally or functionally abnormal protein known that might represent the primary gene product, nor has any pathogenetic mechanism leading to the observed biochemical and histological alterations been elucidated. Among the numerous pathogenetic concepts the hypothesis of a structural or/and functional defect of the muscular plasma membrane is still the most attractive. It would explain both the excess of muscular constituents found in serum of patients and carriers, such as creatine kinase (CK), as well as the excessive calcium uptake by dystrophic muscle fibres, which, prior to necrosis, could lead to hypercontraction, rupture of myofilaments in adjacent sarcomeres and by excessive Ca uptake to mitochondrial damage causing crucial energy loss.

The results of studies on structural and functional memthrane abnormalities in cells other than muscle tissue, e.g., erythrocytes, lymphocytes and cultured fibroblasts, indicate that the DMD mutation is probably demonstrable in these tissues. However, most of the findings are still difficult to reproduce or even controversial.

DMD is an incurable disease; therefore most effort, in research as well as in practical medicine, is concentrated upon its prevention. Unfortunately the disease cannot yet be diagnosed prenatally. Potential DMD carriers among female relatives of the patients may be identified by pathological heterozygote tests, of which determination of serum CK activity is probably still the most reliable method, allowing the detection of about 70% of adult and probably up to 90% of carriers at school age. Because of the high mutation rate, assessment of individual heterozygote risks in female relatives of isolated DMD cases is of special importance. For the calculations a maximum of genealogical and phenotype information on unaffected male and on heterozygote tests in female relatives is needed to obtain credible risk figures. However, estimating a consultand's risk and passing on this information is only one aspect of genetic counselling in DMD. At least as important is information on the medical, psychological and social impacts of the disease (burden) and the possibility of maintaining a long-term contact between the couples at risk and the team involved in medical, genetic and social problems of the disease. Neonatal CK screening for DMD, although without any therapeutical consequence, could theoretically lead to the prevention of “secondary” cases, accounting for some 15% of all DMD patients born, but an almost equal prevention rate of such cases would be achieved if CK examinations were limited to all boys with delayed motor development during the first 2 years of life. Finally, it is believed that the two most important preventive problems in DMD, carrier detection and prenatal diagnosis, will ultimately be solved by means of the rapidly advancing DNA technology.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Accardo PJ (1981) An early case report of muscular dystrophy. A footnote to the history of neuromuscular disorders. Arch Neurol 38:144–146Google Scholar
  2. Adornato BT, Corash L, Engel WK (1977) Erythrocyte survival in Duchenne muscular dystrophy. Neurology 27:1093–1094Google Scholar
  3. Aebi U, Richterich R, Stillhart H, Colombo JP, Rossi E (1961) Progressive Muskeldystrophie. III. Serumenzyme bei der Muskeldystrophie im Kindesalter. Helv Paediatr Acta 16:543–564Google Scholar
  4. Afifi AK, Bergman RA, Zellweger H (1973) A possible role for electron microscopy in detection of carriers of Duchenne type muscular dystrophy. J Neurol Neurosurg Psychiatry 36:643–650Google Scholar
  5. Ahmad M, Sanderson JE, Dubowitz V, Hallidie-Smith KA (1978) Echocardiographic assessment of left ventricular function in Duchenne's muscular dystrophy. Br Heart J 40:734–740Google Scholar
  6. Alberts MC, Samaha FJ (1974) Serum pyruvate kinase in muscle disease and carrier states. Neurology 24:462–464Google Scholar
  7. Allen JE, Rodgin DW (1960) Mental retardation in association with progressive muscular dystrophy. Am J Dis Child 100:208–211Google Scholar
  8. Ando T, Shimizu T, Kato T, Ohsawa M, Fukuyama Y (1978) Myoglobinemia in children with progressive muscular dystrophy. Clin Chim Acta 85:17–22Google Scholar
  9. Araki S, Mawatari S (1971) Ouabain and erythrocyte ghost adenosine triphosphatase. Effects in human muscular dystrophies. Arch Neurol 24:187–190Google Scholar
  10. Austin L, Katz S, Jeffrey PL, Shield L, Arthur H, Mazzoni M (1983) Thermodynamic behaviour of membrane enzymes in Duchenne muscular dystrophy. J Neurol Sci 58:143–151Google Scholar
  11. Ballantyne JP, Hansen S (1974) New method for the estimation of the number of motor units in a muscle: II. Duchenne, limbgirdle and facioscapulohumeral and myotonic muscular dystrophies. J Neurol Neurosurg Psychiatry 37:1195–1201Google Scholar
  12. Becker PE (1953) Dystrophia musculorum progressiva. Thieme, StuttgartGoogle Scholar
  13. Becker PE (1964) Myopathien. In: Becker PE (ed) Humangenetik. Ein kurzes Handbuch in 5 Bänden, Bd III/1. Thieme, Stuttgart, pp 420–427Google Scholar
  14. Becker PE (1972) Neues zur Genetik und Klassifikation der Muskeldystrophien. Humangenetik 17:1–22Google Scholar
  15. Becker PE, Kiener F (1955) Eine neue X-chromosomale Muskeldystrophie. Arch Psychiatr Z Neurol 193:427–448Google Scholar
  16. Becker PE, Lenz F (1955, 1956) Zur Schätzung der Mutationsrate der Muskeldystrophien. Z menschl Vererb Konstitutionsl 33: 42–56Google Scholar
  17. Beckmann R, Scheuerbrandt G (1979) Screening auf erhöhte Kreatinkinase-Aktivitäten zur Früherkennung der Duchenne-Muskeldystrophie. Fortschr Med 97:1733–1736Google Scholar
  18. Berg G, Conte F (1974) Duchenne dystrophy in a female with a structurally abnormal X-chromosome. Neurology 24:356Google Scholar
  19. Bertorini TE, Bhattacharya SK, Palmieri GMA, Chesney CM, Pifer D, Baker B (1982) Muscle calcium and magnesium content in Duchenne muscular dystrophy. Neurology 32:1088–1092Google Scholar
  20. Beyer P, Stephan M, Oberling F, Daya Y (1977) Deformation des erythrocytes chez les sujets atteints de myopathie de Duchenne de Bologne. Presse Méd 6:1663–1664Google Scholar
  21. Biggs R, Rizza CR (1976) The sporadic case of hemophilia A. Lancet ii:431–433Google Scholar
  22. Bitter K (1964) Erhebungen zur Bestimmung der Mutationsrate für Haemophilie A und B in Hamburg. Z Menschl Vererb Konstitutionsl 37:251–268Google Scholar
  23. Blith H, Pugh RJ (1959) Muscular dystrophy in childhood. The genetic aspect. Ann Hum Genet 23:127–163Google Scholar
  24. Bodensteiner JB, Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: A study of 567 000 muscle fibres in 114 biopsies. Neurology 28:439–446Google Scholar
  25. Boulé M, Vanasse M, Brakier-Gingras L (1979) Decrease in the rate of protein synthesis from cultured fibroblasts of patients and carriers with Duchenne muscular dystrophy. J Canad Sci Neurol 6:355–358Google Scholar
  26. Boxler K, Jerusalem F (1978) Hyperreactive (hyaline, opaque, dark) muscle fibres in Duchenne dystrophy. A biopsy study of 16 dystrophy and 205 other neuromuscular disease cases and controls. J Neurol 219:63–72Google Scholar
  27. Bradley WG, Fullthorpe JJ (1978) Studies of sarcolemmal integrity in myopathic muscle. Neurology 28:670–676Google Scholar
  28. Bradley WG, Kelemen J (1979) Editorial: Genetic counseling in Duchenne muscular dystrophy. Muscle and Nerve 2:325–327Google Scholar
  29. Brambati B, Cornelio F, Dworzak F, Dones I (1980) Calciumpositive muscle fibres in fetuses at risk for Duchenne muscular dystrophy. Lancet ii:969–970Google Scholar
  30. Brooks AP, Emery AEH (1977) The incidence of Duchenne muscular dystrophy in the south east of Scotland. Clin Genet 11:290–294Google Scholar
  31. Brown HD, Chattpadhyay SK, Patel AB (1967) Erythrocyte abnormality in human myopathy. Science 157:1577–1578Google Scholar
  32. Brown WF (1974) Sources of error in the methods for estimating motor unit numbers in the EDB and thenar muscles. III International Congress on Muscle Disease. Internat Congr Ser 334, Excerpta Medica, Abstr 190, pp 108–115Google Scholar
  33. Bucher K, Ionasescu V, Hanson J (1980) Frequency of new mutants among boys with Duchenne muscular dystrophy. Am J Med Genet 7:27–46Google Scholar
  34. Bundey S (1981) A genetic study of Duchenne muscular dystrophy in the West Midlands. J Med Genet 18:1–7Google Scholar
  35. Bundey S, Crawley JM, Edwards JH, Westhead RA (1979a) Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women. J Med Genet 16:117–121Google Scholar
  36. Bundey S, Edwards JH, Insley J (1979b) Carrier detection in Duchenne muscular dystrophy. Lancet i:881Google Scholar
  37. Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1981) Analysis of cultured skin fibroblasts from patients with Duchenne muscular dystrophy using electrophoretic techniques. In: Allen RC, Arnaud P (eds) Electrophoresis '81. Walter de Gruyter, Berlin, pp 285–308Google Scholar
  38. Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1982a) Analysis of fibroblast proteins in Duchenne muscular dystrophy: 1. Sodium dodecyl sulphate polyacrylamide gel electrophoresis. Electrophoresis 3:177–185Google Scholar
  39. Burghes AHM, Dunn MJ, Statham HE, Dubowitz V (1982b) Analysis of skin fibroblast proteins in Duchenne muscular dystrophy: 2. Isoelectric focusing under dissociating conditions. Electrophoresis 3:185–196Google Scholar
  40. Butterfield DA, Markesbery WR (1980) Specifity of biophysical and biochemical alterations in erythrocyte membranes in neurological disorders. Huntington's disease, Friedreich's ataxia, Alzheimer's disease, amyotrophic lateral sclerosis, and myotonic and Duchenne muscular dystrophy. J Neurol Sci 47:261–271Google Scholar
  41. Butterfield DA, Chesnut DB, Appel SH, Roses AD (1976) Spin label study of erythrocyte membrane fluidity in myotonic and Duchenne dystrophies and myotonia congenita. Nature 263:159–161Google Scholar
  42. Canal N, Frattola L, Smirne S (1975) The metabolism of cyclic 3′-5′-adenosine monophosphatase (cAMP) in diseased muscle. J Neurol 208:259–265Google Scholar
  43. Canki N, Dutrillaux B, Tivadar I (1979) Dystrophie musculaire de Duchenne chez une petite fille proteuse d'une translocation t(X;3) (p21;q13) de novo. Ann Génet 22:35–39Google Scholar
  44. Carpenter S, Karpati G (1979) Duchenne muscular dystrophy. Plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102:147–161Google Scholar
  45. Carter ND, Heath R, Jeffrey S, Rodeck C (1982) Fetal plasma carbonic anhydrase III in Duchenne dystrophy. Lancet i:39–40Google Scholar
  46. Caskey CT, Nussbaum RL, Cohan LC, Pollack L (1980) Sporadic occurrence of Duchenne muscular dystrophy: evidence for new mutation. Clin Genet 18:329–341Google Scholar
  47. Cerri CG, Willner JH, Mirande AF (1982) Adenylate cyclase in Duchenne fibroblasts. J Neurol Sci 53:181–185Google Scholar
  48. Cheeseman EA, Kilpatrick SJ, Stevenson AC, Smith CAB (1958) The sex ratio of mutation rates of sex-linked recessive genes in man with particular reference to Duchenne type muscular dystrophy. Ann Hum Genet 22:235–243Google Scholar
  49. Chung CS, Morton NE (1959) Discrimination of genetic entities in muscular dystrophy. Am J Hum Genet 11:339–359Google Scholar
  50. Cöers C, Telerman-Topet N, Gerard JH (1973) Terminal innervation ratio in neuromuscular disease: II. Disorders of lower motor neuron, peripheral nerve, and muscle. Arch Neurol 29:215–222Google Scholar
  51. Coneally PM, Heuch I (1974) A computer program to determine genetic risks: a simplified version of PEDIG (Heuch and Li, 1972). Am J Hum Genet 26:773–775Google Scholar
  52. Conlon T, Lingard PS, Tomkins JK (1983) Deformability and cell membrane properties of erthrocytes in Duchenne muscular dystrophy. Clin Chim Acta 130:139–147Google Scholar
  53. Cowan J, MacDessi J, Stark A, Morgan G (1980) Incidence of Duchenne muscular dystrophy in New South Wales and the Australian capital territory. J Med Genet 17:245–249Google Scholar
  54. Crisp DE, Ziter FA, Bray PF (1982) Diagnostic delay in Duchenne's muscular dystrophy. JAMA 247:478–480Google Scholar
  55. Cullen MJ, Fulthorpe JJ (1975) Stages in fibre breakdown in Duchenne muscular dystrophy. J Neurol Sci 24:179–200Google Scholar
  56. Cullen MJ, Parsons R (1977) Inclusion bodies in muscular dystrophy. Lancet ii:929Google Scholar
  57. Cullen MJ, Mastaglia FL (1980) Morphological changes in dystrophic muscle. Br Med Bull 36:145–152Google Scholar
  58. Danieli GA, Mostacciulo ML, Bonfante A, Angelini C (1977) Duchenne muscular dystrophy. A population study. Hum Genet 35:225–231Google Scholar
  59. Danieli GA, Mostacciulo ML, Pilotto G (1978) Duchenne mutation rate. IRCS Medical Science 6:440Google Scholar
  60. Danieli GA, Mostacciulo ML, Pilotto G, Angelini C, Bonfonge A (1980) Duchenne muscular dystrophy. Data from family studies. Hum Genet 54:63–68Google Scholar
  61. Danilowicz D, Rutkowski M, Myung D, Schively D (1980) Echocardiography in Duchenne muscular dystrophy. Muscle and Nerve 3:298–303Google Scholar
  62. Davie AM, Emery AEH (1978) Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet 15:339–345Google Scholar
  63. Davies KE, Young BD, Elles RG, Hill ME, Williamson R (1981) Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature 293: 374–376Google Scholar
  64. Davies KE, Pearson PL, Harper PS, Murray JM, O'Brien T, Sarfarazi M, Williamson R (1983) Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res 11:2303–2312Google Scholar
  65. Dellamonica C, Collombel C, Cotte J, Addis P (1983) Screening for neonatal Duchenne muscular dystrophy by bioluminiscence measurement of creatine kinase in a blood sample spotted on paper. Clin Chem 29:161–163Google Scholar
  66. Dennis NR, Evans K, Clayton B, Carter CO (1976) Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers. Br Med J 2:577–579Google Scholar
  67. Dhalla NS, McNamara DB, Balasubramian V, Greenlaw R, Tucker FR (1973) Alterations of adenosine triphosphatase activities in dystrophic muscle sarcolemma. Res Commun Chem Pathol Pharmacol 6:643–650Google Scholar
  68. Drachman DB, Toyka KV, Myer E (1974) Prednisone in Duchenne muscular dystrophy. Lancet ii:1409–1412Google Scholar
  69. Dreyfus JC, Schapira G (1962) Biochemistry of hereditary myopathies. Springfield, Charles C ThomasGoogle Scholar
  70. Dreyfus JC, Schapira G, Schapira F (1954) Biochemical study of muscle in progressive muscular dystrophy. J Clin Invest 33: 794–797Google Scholar
  71. Drummond LM (1979) Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch Dis Child 54:362–366Google Scholar
  72. Dubowitz V (1960) Progressive muscular dystrophy of the Duchenne type in females and its mode of inheritance. Brain 83:432–439Google Scholar
  73. Dubowitz V (1963) Myopathic changes in muscular dystrophy carriers. Proc R Soc Med 56:810–812Google Scholar
  74. Dubowitz V (1965) Intellectual impairment in muscular dystrophy. Arch Dis Child 40:296–301Google Scholar
  75. Dubowitz V (1978) Muscle disorders in childhood. In: Schaffer AJ, Markowitz M (eds) Major problems in clinical pediatrics, vol XVI. Saunders, London Philadelphia TorontoGoogle Scholar
  76. Dubowitz V (1982) The female carrier of Duchenne muscular dystrophy. Br Med J 284:1423–1424Google Scholar
  77. Dubowitz V, Crome L (1969) The central nervous system in Duchenne muscular dystrophy. Brain 92:805–808Google Scholar
  78. Dubowitz V, Van Iddeninge D, Rodeck CH, Campbell S, Singer JD, Scheuerbrandt G, Moss DW (1978) Prenatal diagnosis in Duchenne muscular dystrophy: salvage of a normal male fetus. Lancet i:90Google Scholar
  79. Duchenne de Boulogne GBA (1861) De l'éctrisation localisée et de son application à la pathologie et la thérapeutique. J. B. Baillière & Pils, ParisGoogle Scholar
  80. Duchenne de Boulogne GBA (1868) Recherches sur la paralysie musculaire pseudohypertrophique, ou paralysie myosclérosique. Arch Gén Méd 11:5–25; 179–209; 305–321; 421–443; 552–588Google Scholar
  81. Duncan CJ (1978) Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experienta 34:1531–1535Google Scholar
  82. Ebashi S, Sugita H (1979) The role of calcium in physiological and pathological processes of skeletal muscle. In: Aguayo AJ, Karpati G (eds) Current topics in nerve and muscle research Amsterdam: Excerpta Medica, ICS No 445, pp 73–84Google Scholar
  83. Ebashi S, Toyokura Y, Momoi H, Sugita H (1959) High creatine phosphokinase activity of sera of progressive muscular dystrophy patients. J Biochem (Tokyo) 46:103–104Google Scholar
  84. Emery AEH (1964) Lyonisation of the X-chromosome. Lancet i:884Google Scholar
  85. Emery AEH (1965) Muscle histology in carriers of Duchenne muscular dystrophy. I Med Genet 2:1–7Google Scholar
  86. Emery AEH (1966a) Genetic linkage between the loci for colour blindness and Duchenne type muscular dystrophy. J Med Genet 3:92–95Google Scholar
  87. Emery AEH (1966b) The use of serum creatine kinase for detecting carriers of Duchenne muscular dystrophy. In: Exploratory concepts in muscular dystrophy and related disorders. International Congress Series No 147 Excerpta Medica, Amsterdam, pp 90–97Google Scholar
  88. Emery AEH (1969a) Abnormalities of the electrocardiogram in female carriers of Duchenne muscular dystrophy. Br Med J 2: 418–420Google Scholar
  89. Emery AEH (1969b) Genetic counselling in X-linked muscular dystrophy. J Neurol Sci 8:579–587Google Scholar
  90. Emery AEH (1977a) Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature 266: 472–473Google Scholar
  91. Emery AEH (1977b) Genetic considerations in the X-linked muscular dystrophies. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Excerpta Medica Amstedam, pp 42–58Google Scholar
  92. Emery AEH (1980) Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br Med Bull 36:117–122Google Scholar
  93. Emery AEH (1981) Genetic aspects of neuromuscular disease. In: Walton J (ed) Disorders of voluntary muscle, 4th ed. Churchill Livingstone, Edinburgh London Melbourne New York, pp 785–807Google Scholar
  94. Emery AEH, Skinner R (1976) Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin Genet 10:189–201Google Scholar
  95. Emery AEH, Holloway S (1977) Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne muscular dystrophy. Hum Hered 27:118–126Google Scholar
  96. Emery AEH, Burt D (1980) Intracellular calcium and pathogenesis and antenatal diagnosis of Duchenne muscular dystrophy. Br Med J 1:355–357Google Scholar
  97. Emery AEH, Smith CAB, Sanger R (1968/1969) The linkage relations of the loci for benign (Becker type) X-borne muscular dystrophy, colour blindness and the Xg blood groups. Ann Hum Genet 32:261–269Google Scholar
  98. Emery AEH, Watt MS, Clack ER (1972) The effects of genetic counselling in Duchenne muscular dystrophy. Clin Genet 3: 147–150Google Scholar
  99. Emery AEH, Burt D, Dubowitz V, Rocker I, Donnai D, Harris R, Donnai P (1979a) Antenatal diagnosis of Duchenne muscular dystrophy. Lancet i:847–849Google Scholar
  100. Emery AEH, Skinner R, Holloway S (1979b) A study of possible heterogeneity in Duchenne muscular dystrophy. Clin Genet 15:444–449Google Scholar
  101. Engel WK (1967) Muscle biopsies in neuromuscular diseases. Pediatr Clin N Am 14:963–965Google Scholar
  102. Engel WK (1971) Nouvelle hypothèse sur la pathogénie de la dystrophie musculaire pseudo-hypertrophique de Duchenne. Rev Neurol 124:291–298Google Scholar
  103. Erb WH (1891) Dystrophia muscularis progressiva: Klinische und pathologisch anatomische Studien. Dtsch Z Nervenheilk 1:13–94Google Scholar
  104. Eulenburg von A (1866) Ergebnisse der anatomischen Untersuchung eines Falles von sogenannter Muskelhypertrophie. Verhandl Berliner Med Gest 1:191Google Scholar
  105. Falk RS, Campion D, Guthrie D, Sparkes RS, Fox CF (1979) Phosphorylation of red-cell membrane proteins in Duchenne muscular dystrophy. N Engl J Med 300:258–259Google Scholar
  106. Fenichel GM (1975) On the pathogenesis of Duchenne muscular dystrophy. Dev Med Child Neurol 17:527–533Google Scholar
  107. Ferrier P, Bamatter F, Klein D (1965) Muscular dystrophy (Duchenne) in a girl with Turner's syndrome. J Med Genet 2:38–46Google Scholar
  108. Firth MA, Wilkinson EJ (1983) Screening the newborn for Duchenne muscular dystrophy: parents' view. Br Med J 286:1933–1934Google Scholar
  109. Fischer S, Tortolero M, lau JP, Delauney J, Schapira G (1978) Protein kinase and adenylate cyclase or erythrocyte membrane proteins from patients with Duchenne muscular dystrophy. Clin Chim Acta 88:437–440Google Scholar
  110. Fisher ER, Wissinger HA, Gerneth JA, Danowski TS (1972) Ultrastructural changes in skeletal muscle of muscular dystrophy carriers. Arch Pathol 94:456–460Google Scholar
  111. Fisher ER, Silverstri E, Vester JW, Nolan S, Ahmed U, Danowski T (1976) Increased erythrocyte osmotic fragility in pseudohypertrophic muscular dystrophy. JAMA 236:955Google Scholar
  112. Francke U, Felsenstein J, Gartler SM, Migeon BR, Dancis J, Seegmiller JE, Bakay F, Nyhan WL (1976) The occurrence of new mutants in the X-linked recessive Lesch-Nyhan disease. Am J Hum Genet 28:123–137Google Scholar
  113. Francke U, Felsenstein J, Gartler SM, Nyhan WL, Seegmiller JE (1977) Answer to criticism of Morton and Laloue (Letter to the editor). Am J Hum Genet 29:307–310Google Scholar
  114. Fritsch EF, Lawn RM, Maniatis T (1980) Molecular cloning and characterization of the human β-like globin gene cluster. Cell 19:959–972Google Scholar
  115. Fuhrmann W, Vogel F (1982) Genetische Familienberatung. Ein Leitfaden für Studierende und Aerzte, 3. Aufl. Springer, Berlin Heidelberg New YorkGoogle Scholar
  116. Gaines RF, Pueschel SM, Sassaman EA, Driscoll JL (1982) Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy. J Med Genet 19:4–7Google Scholar
  117. Gale AN, Murphy EA (1979) The use of serum creatine phosphokinase in genetic couseling for Duchenne muscular dystrophy. II: Review of methods of assay and factors which may be relevant in the interpretation of serum creatine phosphokinase activity. J Chron Dis 32:639–651Google Scholar
  118. Gardner-Medwin D (1968) Studies of the carrier state in Duchenne type muscular dystrophy. Quantitative electromygraphy as a method of carrier detection. J Neurol Neurosurg Psychiatr 31: 121–134Google Scholar
  119. Gardner-Medwin D (1970) Mutation rate in Duchenne type of muscular dystrophy. J Med Genet 7:334–337Google Scholar
  120. Gardner-Medwin D (1979) Controversies about Duchenne muscular dystrophy. (1) Neonatal screening. Dev Med Child Neurol 21: 390–393Google Scholar
  121. Gardner-Medwin D (1980) Clinical features and classification of the muscular dystrophies. Br Med Bull 36:109–115Google Scholar
  122. Gardner-Medwin D, Pennington RJ, Walton JN (1971) The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne. J Neurol Sci 13:459–474Google Scholar
  123. Gardner-Medwin D, Bundey S, Green S (1978) Early diagnosis of Duchenne muscular dystrophy. Lancet i:1102Google Scholar
  124. Garceau C, Leblond PF, Lyonnais J, Beaupré A (1978) Morphologie et déformabilité des érythrocytes dans la dystrophie musculaire. Nouv Rev Fr Hématol Blood Cells 20:585–598Google Scholar
  125. Gershwin ME, Taylor RG, Fowler WM, Finlayson B (1979) Failure to demonstrate abnormal lymphocyte capping in humans, mice and hamsters with muscular dystrophy. Hum Genet 53:113–114Google Scholar
  126. Godin DV, Bridges MA, MacLeod PJM (1978) Chemical composition studies of erythrocyte membranes in Duchenne muscular dystrophy. Res Commun Chem Pathol Pharmacol 20:331–350Google Scholar
  127. Golbus MS, Stephens JD, Mahoney MJ, Hobbins JC, Haseltine FP, Caskey CT, Banker BQ (1979) Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. N Engl J Med 300:860–861Google Scholar
  128. Goldsmith BM, Gruemer HD, Hawley RJ, Pickard NA, Verril HL, Nance WE, Miller G, Crawford RG (1980) The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait. Clin Chem 26:754–759Google Scholar
  129. Gossens M, Dozy AM, Embyry SH, Zachariades Z, Hadjiminas MG, Stamatoyannopoulos G, Kan YW (1980) Triplicated α-globin loci in humans. Proc Natl Acad Sci 77:518–521Google Scholar
  130. Gowers WR (1879) Pseudo-hypertrophic muscular paralysis. J A Churchill, LondonGoogle Scholar
  131. Grassi E, Lucci B, Marchini C, Ottonello S, Parma M, Reggiani R, Rossi GL, Tagliavini J (1977) II problema delle alterazioni eritrocitarie (echnio e stomatocitche) nella distrofia muscolare. Ateno Parmense (Acta Biomed) 48:297–327Google Scholar
  132. Grassi E, Lucci B, Marchini C, Ottonello S, Parma M, Reggiani R, Rossi GL, Tagliavini J (1978) Deformed erythrocytes in muscular dystrophies. Neurology 28:842–844Google Scholar
  133. Greenstein RM, Reardon MP, Chan TS, Middleton AB, Mulivor RA, Green AE, Coriell LL (1980) An (X;11) translocation in a gril with Duchenne muscular dystrophy. Repository identification no. GM 1695. Cytogenet Cell Genet 27:268Google Scholar
  134. Grimm T (1981) Neugeborenen-Screening nach Duchennescher Muskeldystrophie. Monatsschr Kinderheilk 129:414–417Google Scholar
  135. Haldane JBS (1935) The rate of spontaneous mutation of a human gene. J Genet 31:317–326Google Scholar
  136. Haldane JBS (1956) Mutation in the sex-linked recessive type of muscular dystrophy. A possible sex difference. Ann Hum Genet 20:344–347Google Scholar
  137. Hammond DT, Jackson CE (1958) Consanguinity in a midwestern United States isolate. Am J Hum Genet 10:61–63Google Scholar
  138. Hathaway PW, Engel WK, Zellweger H (1970) Experimental myopathy after microarterial embolization. Comparison with childhood X-linked pseudohypertrophic muscular dystrophy. Arch Neurol 22:365–377Google Scholar
  139. Hauser SL, Weiner H, Ault K, Unanue E (1979a) Lymphocyte capping in muscular dystrophy. N Engl J Med 300:861Google Scholar
  140. Hauser SL, Weiner HL, Bresnan MJ, Ault KA (1979b) Lymphocyte capping in muscular dystrophy. Neurology 29:1419–1421Google Scholar
  141. Hausmanowa-Petrusewicz I, Prot J, Niebrój-Dobosz I (1968) Studies of healthy relatives of patients with Duchenne muscular dystrophy. J Neurol Sci 7:465–480Google Scholar
  142. Hausmanowa-Petrusewicz I, Prot J, Dobosz I, Emeryk B, Roswinska K, Rubach K, Kopéc A, Kopéc J (1971) Further studies concerning the detection of carriership in the Duchhenne type of dystrophy. Eur Neurol 5:186–196Google Scholar
  143. Hausmanowa-Petrusewicz I, Niebroj-Dobosz I, Borkowsak J, Lukasik E, Liszewska-Pfejfer D (1977) Carrier detection in Duchenne dystrophy. In: Rowland LP (ed) Pathogenesis of human muscular dystrophies. Amsterdam, Excerpta Medica, pp 32–41Google Scholar
  144. Hausmanowa-Petrusewicz I, Wierzhicka M, Jozwik A, Szmidt-Salkowska E, Borkowska J (1982) A nearest neighbur decision rule for EMG detection of carriers of Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol 22:445–457Google Scholar
  145. Heller A (1866) Klinische Beobachtungen über die bisher als Muskelhypertrophie bezeichnete Lipomatosis luxurians musculorum progressiva. Dtsch Arch Klin Med 1:616Google Scholar
  146. Herrmann FH, Spiegler A, Wiedemann G (1982) Muscle provocation test. A sensitive method for discrimination between carriers and noncarriers of Duchenne muscular dystrophy. Hum Genet 61:102–104Google Scholar
  147. Herrmann J (1966) Der Einfluss des Zeugungsalters auf die Mutation zu Hämophilie A. Humangenetik 3:1–16Google Scholar
  148. Heuch I, Li FHF (1972) PEDIG—a computer programme for calculation of genotype probabilities using phenotype information. Clin Genet 3:501–504Google Scholar
  149. Heyck H, Laudahn G (1969) Die progressiv-dystrophischen Myopathien. Springer, BerlinGoogle Scholar
  150. Hinderberger P, Moser H, Beck EA, Pflugshaupt R (1980) Heterozygotenerfassung bei der Hämophilie A—Genealogische und biochemische Resultate einer Feldstudie and 25 Bluterfamilien. Schweiz Rundschau Med (PRAXIS) 69:1349–1360Google Scholar
  151. Ho AD, Reitter B, Stojakowits S, Fiehn W, Weisser J (1980a) Capping of lymphocytes for carrier detection in Duchenne muscular dystrophy: Technical problems and a review of the literature. Eur J Pediatr 134:211–216Google Scholar
  152. Ho AD, Stojakowits S, Reitter B, Fiehn W, Zipperle G, Hunstein E, Lipinski CH (1980b) Capping of lymphocytes in patients and carriers of Duchenne muscular dystrophy. Klin Wschr 58:377–381Google Scholar
  153. Hodson A, Pleasure D (1977) Erythrocyte cation-activated adenosine triphosphatases in Duchenne muscular dystrophy. J Neurol Sci 32:361–369Google Scholar
  154. Horenstein AL, Emery AEH (1980) Human lymphocyte capping in Duchenne muscular dystrophy. Neurology 30:1330–1332Google Scholar
  155. Howells KF (1976) Structural changes of erythrocyte membranes in muscular dystrophy. Res Exp Med 168:213–217Google Scholar
  156. Howland JL, Iver SL (1977) Erythrocyte lipids in heterozygous carriers of Duchenne muscular dystrophy. Science 198:309–310Google Scholar
  157. Hudgson P, Gardner-Medwin D, Pennington RJT, Walton JN (1967) Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity. J Neurol Neurosurg Psychiatry 30:416–419Google Scholar
  158. Hughes RC, Park DC, Parsons ME, O'Brien MD (1971) Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy. J Neurol Neurosurg Psychiatry 34:527–530Google Scholar
  159. Hulten M, Luciani JM, Kirton V, Devictor-Vullet M (1978) The use and limitations of chiasma scoring with reference to human genetic mapping. Cytogenet Cell Genet 22:37–58Google Scholar
  160. Hunsaker RH, Fulkerson PK, Barry FJ, Lewis RP, Leier CV, Unverferth DV (1982) Cardiac function in Duchenne's muscular dystrophy. Results of 10-year-follow-up study and noninvasive tests. Am J Med 73:235–238Google Scholar
  161. Hunter MIS, Lao MS, de Vane PJ (1982) Is erythrocyte membrane phospholipid organisation abnormal in Duchenne muscular dystrophy. Clin Chim Acta 128:69–74Google Scholar
  162. Hutton EM, Thompson MW (1976) Carrier detection and genetic counselling in Duchenne muscular dystrophy. A follow-up study. Can Med Ass J 115:749–752Google Scholar
  163. Ionasescu V, Zellweger H (1974) Duchenne muscular dystrophy in young girls? Acta Neurol Scand 50:619–630Google Scholar
  164. Ionasescu V, Zellweger H, Shirk P, Conway T (1973) Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis. Neurology 23:497–502Google Scholar
  165. Ionasescu V, Radu H, Nicolescu P (1975) Identification of Duchenne muscular dystrophy carriers. Arch Pathol 99:436–441Google Scholar
  166. Ionasescu V, Lara-Braud C, Zellweger H, Ionasescu R, Burmeister L (1977) Fibroblast cutures in Duchenne muscular dystrophy. Acta Neurol Scand 55:407–417Google Scholar
  167. Ionasescu V, Zellweger H, Cancilla P (1978) Fetal serum creatine phosphokinase not a valid predictor of Duchenne muscular dystrophy. Lancet ii:1251Google Scholar
  168. Ionasescu V, Burmeister L, Hanson J (1980) Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy. Am J Med Genet 5:5–12Google Scholar
  169. Iyer SL, Hoenig PA, Sherblom AP, Howland JL (1977) Membrance function affected by genetic muscular dystrophy. I. Erythrocyte ghost protein kinase. Biochem Med 18:384–391Google Scholar
  170. Jackson CE, Carey JH (1961) Progressive muscular dystrophy: autosomal recessive type. Pediatrics 28:77–84Google Scholar
  171. Jacobs PA, Hunt PA, Mayer M, Bart RD (1981) Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: Further evidence that the DMD locus in at Xp21. Am J Hum Genet 33:513–518Google Scholar
  172. Jalbert P, Mouriquand C, Beaudoing A, Jaillard M (1966) Myopathie progressive de type Duchenne et mosaique XO/XX/XXX: Considération sur la génèse de la fibre musculaire striée. Ann Génét 9:104–108Google Scholar
  173. Jellett LB, Kennedy MC, Goldblatt E (1974) Duchenne pseudohypertrophic muscular dystrophy. A clinical and electrocardiographic study of patients and female carriers. Aust NZ J Med 4:41–47Google Scholar
  174. Jerusalem F, Engel AG, Gomez MR (1974a) Duchenne dystrophy: Morphometric study of the muscle microvasculature. Brain 97: 115–122Google Scholar
  175. Jerusalem F, Engel AG, Gomez MR (1974b) Duchenne dystrophy: II. Morphometric study of motor end-plate fine structure. Brain 97:123–130Google Scholar
  176. Johnston HA (1964) Severe muscular dystrophy in girls. J Med Genet 1:79–81Google Scholar
  177. Jones GE, Witkowski JA (1979) Reduced adhesiveness between skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 43:465–470Google Scholar
  178. Jones GE, Witkowski JA (1981) Analysis of skin fibroblasts from patients with Duchenne muscular dystrophy. J Cell Sci 48: 291–300Google Scholar
  179. Jones GE, Witkowski JA (1983a) Membrane abnormalities in Duchenne muscular dystrophy. J Neurol Sci 58:159–174Google Scholar
  180. Jones GE, Severs NJ, Witkowski JA (1983) Freeze-fracture analysis of plasma membranes in Duchenne muscular dystrophy. A study using cultured skin fibroblasts. J Neurol Sci 58:185–193Google Scholar
  181. Jones GE, Witkowski JA (1983b) A cell surface abnormality in Duchenne muscular dystrophy: intercellular adhesiveness of skin fibroblatts from patients and carriers. Hum Genet 63:232–237Google Scholar
  182. Jones KW (1980) Muscle cell differentiation and the prospects for the genetic engineering. Br Med Bull 36:173–180Google Scholar
  183. Kalofoutis A, Jullien G, Spanos V (1977) Erythrocyte phospholipids in Duchenne muscular dystrophy. Clin Chim Acta 74:85–87Google Scholar
  184. Kar NC, Pearson CM (1976) Ca-activated neutral protease in normal and dystrophic human muscle. Clin Chim Acta 73:293–297Google Scholar
  185. Kar NC, Pearson CM (1978) Muscular dystrophy and activation of proteinases. Muscle and Nerve 1:308–313Google Scholar
  186. Khoklov AP, Malakhovsky VK (1978) Characteristics of cyclic 3′,5′-AMP turnover in patients with progressive muscular atrophy. Vopr Med Khim 27:754–758Google Scholar
  187. Kim HD, Luthra MG, Watts RP, Stern LZ (1979) Factors influencing osmotic fragility of Duchenne red blood cells. Ann Neurol 6:153Google Scholar
  188. Kingston HM, Thomas NST, Pearson PL, Sarfarazi M, Harper PS (1983) Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet 20:255–258Google Scholar
  189. Klassen GA, Blostein R (1969) Adenosine triphosphatase and myopathy. Science 163:492–493Google Scholar
  190. Kloepfer HW, Talley C (1958) Autosomal recessive inheritance of Duchenne type muscular dystrophy. Ann Genet 22:138–143Google Scholar
  191. Kobayashi T, Mawatari S, Kuroiwa Y (1978) Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy. Clin Chim Acta 85:259–266Google Scholar
  192. Koehler JP (1974) Blood vessel structure in Duchenne muscular dystrophy. Neurology 24:354Google Scholar
  193. Kohlschütter A, Wiesmann UN, Herschkowitz NN, Ferber E (1976) Phospholipid composition of cultivated skin fibroblasts in Duchenne muscular dystrophy. Clin Chim Acta 70:463–465Google Scholar
  194. Koski CL, Jungalwala FB, Kolodny EH (1978) Normality of erythrocyte phospholipids in Duchenne muscular dystrophy. Clin Chim Acta 85:295–298Google Scholar
  195. Kosower D, Christiansen R, Morton NE (1962) Sporadic cases of hemophilia and the question of a possible sex-difference in mutations. Am J Hum Genet 14:159–169Google Scholar
  196. Kuby SA, Keutel HJ, Okabe K, Jacobs HK, Ziter F, Gerber D, Tyler FH (1977) Isolation of human ATP-creatine transphosphorylases (creatine phosphokinases) from tissues of patients with Duchenne muscular dystrophy. J Biol Chem 252:8382–8390Google Scholar
  197. Kuby SA, Palmieri RH, Okabe K, Frischat A, Cress MC (1979) Studies on muscular dystrophy: a comparison by physical and chemical means of the normal human ATP-creatine transphosphorylases (creatine kinases) with those from tissues in Duchenne dystrophy. Arch Biochem Biophys 194:236–253Google Scholar
  198. Kunze D, Reichmann G, Egger E, Leuschner G, Eckhardt H (1973) Erythrozytenlipide bei progressiver Muskeldystrophie. Clin Chim Acta 43:333–341Google Scholar
  199. Kuroiwa Y, Miyazaki T (1967) Epidemiological study of myopathy in Japan. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy and related disorders. Excerpta Medica, Amsterdam. Int Congr Ser 147, p 98Google Scholar
  200. Lane RJM, Maskrey P, Nicholson GA, Siddiqui PQR, Nicholson M, Gascoigne P, Pennington RJT, Gardner-Medwin D, Walton JN (1979) An evaluation of some carrier detection techniques in Duchenne muscular dystrophy. J Neurol Sci 43:377–394Google Scholar
  201. Lane RJM, Gardner-Medwin D, Roses AD (1980) Electrocardiographic abnormalities in carriers of Duchenne muscular dystrophy. Neurology 30:497–501Google Scholar
  202. Lane RJM, Robinow M, Roses AD (1983) The genetic status of mothers of isolated cases of Duchenne muscular dystrophy. J Med Genet 20:1–11Google Scholar
  203. Lange K, Zatz M (1979) A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Hum Hered 29:154–160Google Scholar
  204. Leder P (1978) Discontinuous genes. N Engl J Med 298:1079–1081Google Scholar
  205. Leibowitz D, Dubowitz V (1981) Intellect and behaviour in Duchenne muscular dystrophy. Dev Med Child Neurol 23:577–590Google Scholar
  206. Liechti-Gallati S, Moser H, Siegrist HP, Wiesmann U, Herschkowitz NN (1981) Abnormal growth kinetics and 5′-nucleotidase activities in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 15:1411–1414Google Scholar
  207. Lindenbaum RH, Clarke G, Patel C, Moncrieff M, Hughes JT (1979) Muscular dystrophy in an X;1 translocation female suggests that Duchenne locus is on X chromosome short arm. J Med Genet 16:389–392Google Scholar
  208. Little WJ (1853) On the nature and treatment of the deformities of the human frame: being a course of lectures delivered at the Royal Orthopaedic Hospital in 1843: With numerous notes and additions to the present time. Longman, Brown, Greene & Longmans, pp 14–16Google Scholar
  209. Lloyd SJ (1978) Osmotic fragility of erythrocytes in Duchenne muscular dystrophy. Br Med J 2:252Google Scholar
  210. Lyon MF (1962) Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet 14:135–148Google Scholar
  211. Mahoney MJ, Haseltine FP, Hobbins JC, Banker BQ, Caskey CT, Golbus MS (1977) Prenatal diagnosis of Duchenne's muscular dystrophy. N Engl J Med 297:968–973Google Scholar
  212. Marsh GG, Munsat TL (1974) Evidence for early impairment of verbal intelligence in Duchenne muscular dystrophy. Arch Dis Child 49:118–122Google Scholar
  213. Matheson DW, Howland JL (1974) Erythrocyte deformation in human muscular dystrophy. Science 184:165–166Google Scholar
  214. Matheson DW, Howland JL (1975) Erythrocytes in human muscular dystrophy. Science 187:453–454Google Scholar
  215. Maunder-Sewry CA, Dubowitz V (1981) Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy-histology, histochemistry and quantitation. J Neurol Sci 49:305–324Google Scholar
  216. Mawatari S, Takagi A, Rowland LP (1974) Adenyl cyclase in normal and pathological human muscle. Arch Neurol 30:96–102Google Scholar
  217. Mawatari S, Miranda A, Rowland LP (1976a) Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture. Neurology 26:1021–1026Google Scholar
  218. Mawatari S, Schonberg M, Olarte M (1976b) ATPase and adenyl cyclase in erythrocytes of patients with Duchenne muscular dystrophy. Arch Neurol 33:489–493Google Scholar
  219. Mawatari S, Igisu H, Kuroiwa Y, Miyoshino S (1981) Na+K+ATPase of erythrocyte membranes in Duchenne muscular dystrophy. Neurology 31:293–297Google Scholar
  220. McComas AJ, Sica REP, Currie S (1970) Muscular dystrophy: evidence for a neural factor. Nature 226:1263–1264Google Scholar
  221. McComas AJ, Sica REP, Campbell MJ (1971a) An electrophysiological study of Duchenne dystrophy. J Neurol Neurosurg Psychiatry 34:461–468Google Scholar
  222. McComas AJ, Sica REP, Campbell MJ (1971b) “Sick” motoneurones: A unifying concept of muscle disease. Lancet i:321–325Google Scholar
  223. McComas AJ, Sica REP, Upton ARM (1974) Multiple analysis of motor units in muscular dystrophy. Arch Neurol 30:249–251Google Scholar
  224. McLaughlin J, Engel WK (1979) Lipid composition of erythrocytes. Finding in Duchenne's muscular dystrophy and myotonic atrophy. Arch Neurol 36:351–354Google Scholar
  225. McMurchie EJ, Williams RE, Sparkes RS, Fox CF (1979) Altered cell surface organization in cultured Duchenne muscular dystrophic fibroblasts. Proc Aust Biochem Soc 12:30Google Scholar
  226. Mendell JR, Engel WK, Derrer EC (1971) Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions. Science 172:1143–1145Google Scholar
  227. Meryon E (1852) On granular and fatty degeneration of the voluntary muscles. Med Chir Trans 35:73–84Google Scholar
  228. Meryon E (1864) Practical and pathological researches on the various forms of paralysis. Churchill, LondonGoogle Scholar
  229. Miale TP, Frias JL, Lawson DL (1975) Erythrocytes in human muscular dystrophy. Science 187:453–454Google Scholar
  230. Milhorat AT, Goldstone L (1965) The carrier state in muscular dystrophy of the Duchenne type. JAMA 194:130–134Google Scholar
  231. Miller SE, Roses AD, Appel SH (1975) Erythrocytes in human muscular dystrophy. Science 188:1131Google Scholar
  232. Miller SE, Roses AD, Appel SH (1976) Scanning electron microscopy studies in muscular dystrophy. Arch Neurol 33:172–174Google Scholar
  233. Miyoshi K, Saito S, Kawai H, Kondo A, Iwasa M, Hayashi T, Yagita M (1978) Radioimmunoassay for human myoglobin: Methods and results in patients with skeletal muscle or myocardial disorders. J Lab Clin Med 92:341–352Google Scholar
  234. Mokri B, Engel AG (1975) Duchenne dystrophy: Electronmicroscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25:1111–1120Google Scholar
  235. Monckton G, Marusyk H, Pehowich E (1981) A method for the detection of carriers of Duchenne muscular dystrophy—A preliminary report. Am J Hum Genet 33:978–986Google Scholar
  236. Monckton G, Hoskin V, Warren S (1982) Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin Genet 21:19–24Google Scholar
  237. Moosa A, Brown BH, Dubowitz V (1972) Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique. J Neurol Neurosurg Psychiatry 35:841–844Google Scholar
  238. Morris CJ, Raybould JA (1971) Histochemically demonstrable fibre abnormalities in normal skeletal muscle and in muscle from carriers of Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 34:348–352Google Scholar
  239. Morris GE, Buzash EA, Bourke AW, Tepperman K, Thompson WC, Heywood SM (1973) Myosin messenger RNA: Studies on its purification, properties and translation during myogenesis in culture. In: The mechanism of muscle contraction. Cold Spring Harbor Symp Quant Biol 37:535–541Google Scholar
  240. Morton NE (1958) Segregation analysis in human genetics. Science 127:79–80Google Scholar
  241. Morton NE, Chung CS (1959) Formal genetics of muscular dystrophy. Am J Hum Genet 11:360–379Google Scholar
  242. Moser H (1976/1977) Bestimmung der Heterozygotenwahrscheinlichkeit bei Angehörigen „sporadischer” Fälle X-chromosomal-rezessiver Erbleiden. Arch Genet 49/50:113–126Google Scholar
  243. Moser H (1977) Heterozygotenerfassung und genetische Beratung bei der progressiven Muskeldystrophie Duchenne. Schweiz Rundschau Med (PRAXIS) 66:814–822Google Scholar
  244. Moser H (1983) Unpublished dataGoogle Scholar
  245. Moser H, Wiesmann U (1971) Serum-Creatin-Kinase und Sulfhydrilarmmuskulatur bei Patienten und Konduktorinnen der progressiven Muskeldystrophie Duchenne. Klin Wschr 49:488–494Google Scholar
  246. Moser H, Emery AEH (1974) The manifesting carrier in Duchenne muscular dystrophy. Clin Genet 5:271–284Google Scholar
  247. Moser H, Vogt J (1974) Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy. Lancet ii:661–662Google Scholar
  248. Moser H, Wiesmann U, Richterich R, Rossi E (1964) Progressive Muskeldystrophie. VI. Häufigkeit, Klinik und Genetik der Duchenne-Form. Schweiz Med Wschr 95:1610–1621Google Scholar
  249. Moser H, Mumenthaler M, Wiesmann U (1971) Biochemische, histologische und klinische Befunde bei Konduktorinnen der progressiven Muskeldystrophie vom Typ Duchenne. Schweiz Med Wschr 101:537–542; 573–578Google Scholar
  250. Munsat TL, Bradley WG (1977) Serum creatine phosphokinase levels and prednisone-treated muscle weakness. Neurology 27:96–97Google Scholar
  251. Munsat TL, Baloh R, Pearson CM, Fowler W Jr (1973) Serum enzyme alterations in neuromuscular disorders. JAMA 226:1536–1542Google Scholar
  252. Murphy EA, Mutalik GS (1969) The application of Bayesian methods in genetic counselling. Hum Hered 19:126–151Google Scholar
  253. Murphy EA, Chase GA (1975) Principles of genetic counseling. Year Book Med Publ, ChicagoGoogle Scholar
  254. Murphy EG, Corey PNJ, Conen PE (1964) Varying manifestations of Duchenne muscular dystrophy in a family with affected females. In: Paul WM, Daniel EE, Kay CM, Monckton G (eds) Muscle (Proceedings of Symposium at Faculty of Medicine, University of Alberta). Pergamon, New York, pp 529–546Google Scholar
  255. Murray JM, Davies KE, Harper PS, Meredith L, Mueller CR, Williamson R (1982) Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 300:69–71Google Scholar
  256. Nicholson LVB (1981) Serum myoglobin in muscular dystrophy and carrier detection. J Neurol Sci 51:411–426Google Scholar
  257. Nicholson GA, Sugars J (1982a) Decreased A 23187-induced chemiluminiscence in Duchenne muscular dystrophy granulocytes. J Neurol Sci 56:11–16Google Scholar
  258. Nicholson GA, Sugars J (1982b) An evaluation of lymphocyte capping in Duchenne muscular dystrophy. J Neurol Sci 53:511–518Google Scholar
  259. Nicholson GA, Gardner-Medwin G, Pennington RJT, Walton JN (1979) Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity. Lancet i:692–694Google Scholar
  260. Nicholson GA, Lane RJM, Gardner-Medwin D, Walton JN (1981) Carrier testing in families of isolated cases of Duchenne muscular dystrophy. Creatine kinase activities in female relatives of mothers with normal CK activity. J Neurol Sci 51:29–42Google Scholar
  261. Niebroj-Dobosz I (1976) Erythrocyte ghosts (Na+K+) ATPase activity in Duchenne's dystrophy and myotonia. J Neurol 214:61–69Google Scholar
  262. Nomura H, Hizawa K (1982) Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy. Acta Pathol Jpn 32:1027–1033Google Scholar
  263. Nordal HJ, Andersson TR, Dietrichson P (1982) Lymphocyte capping: A diagnostic method in progressive muscular dystrophy? Acta Neurol Scand 65:442–447Google Scholar
  264. Nørregaard-Hansen K, Sørensen OH (1982) Significance of serum myoglobin in neuromuscular diseases and in carrier-detection of Duchenne muscular dystrophy. Acta Neurol Scand 66:259–266Google Scholar
  265. Oberc MA, Engel WK (1977) Ultrastructural localization of calcium in normal and abnormal skeletal muscle. Lab Invest 36:566–577Google Scholar
  266. O'Brien T, Harper PS, Davies KE, Murray JM, Sarfarazi M, Williamson R (1983) Absence of genetic heterogeneity in Duchenne muscular dystrophy shown by a linkage study using two cloned DNA sequences. J Med Genet 20:249–251Google Scholar
  267. Olson BJ, Fenichel GM (1982) Progressive muscle disease in a young woman with family history of Duchenne's muscular dystrophy. Arch Neurol 39:378–380Google Scholar
  268. Osame M, Engel AG, Rebouche CJ, Scott RE (1981) Freeze-fracture electron microscopic analysis of plasma membranes of cultured muscle cells in Duchenne dystrophy. Neurology 31:972–979Google Scholar
  269. Panayiotopoulos CP (1974) Electrophysiological estimation of motor units in Duchenne muscular dystrophy. J Neurol Sci 23:89–98Google Scholar
  270. Paterson BM, Bishop JO (1977) Changes in the mRNA population of chick myoblasts during myogenesis in vitro. Cell 12:751–765Google Scholar
  271. Paulson OB, Engel AG, Gomez MR (1974) Muscle blood flow in Duchenne type muscular dystrophy, limb-girdle dystrophy, polymyositis, and in normal controls. J Neurol Neurosurg Psychiatry 37:685–690Google Scholar
  272. Pearce GW, Pearce JMS, Walton JN (1966) The Duchenne type muscular dystrophy: Histopathological studies of the carrier state. Brain 89:109–120Google Scholar
  273. Pearce JMS, Pennington RJT, Walton JN (1964) Serum enzyme studies in muscle disease. Part III. Serum creatine kinase activity in relatives of patients with the Duchenne type of muscular dystrophy. J Neurol Neurosurg Psychiatry 27:181–185Google Scholar
  274. Pearson CM (1962) Histopathological features of muscle in the preclinical stages of muscular dystrophy. Brain 85:109–120Google Scholar
  275. Pearson CM, Fowler WM, Wright SW (1963) X-chromosome mosaicism in females with muscular dystrophy. Proc Natl Acad Sci 50:24–31Google Scholar
  276. Pearson TW (1978) (Na++K+)-ATPase of Duchenne muscular dystrophy erythrocyte ghosts. Life Sci 22:127–132Google Scholar
  277. Pena DJ (1978) Is Duchenne muscular dystrophy a simple genic disorder? Lancet ii:630Google Scholar
  278. Penn AS, Lisak RP, Rowland P (1970) Muscular dystrophy in young girls. Neurology 20:147–159Google Scholar
  279. Penn AS, Cloak EA, Rowland LP (1972) Myosin from normal and dystrophic human muscle: immunchemical and electrophoretic studies. Arch Neurol 27:159–173Google Scholar
  280. Pennington RJT (1977) Proteinases of muscle. In: Barrett AJ (ed) Proteinases in mammalian cells and tissues. Amsterdam, North Holland Publishing Co, pp 515–543Google Scholar
  281. Penrose LS (1955) Parental age and mutation. Lancet ii:312–313Google Scholar
  282. Percy ME, Chang LS, Murphy EG, Oss I, Verellen-Dumoulin C, Thompson MW (1979) Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle and Nerve 2:329–339Google Scholar
  283. Pestronk A, Parhad IM, Drachman DB, Price DL (1982) Membrane myopathy: Morphological similarities to Duchenne muscular dystrophy. Muscle and Nerve 5:209–214Google Scholar
  284. Peter JB, Worsfold M (1969) Muscular dystrophy and other myopathies: sarcotubular vesicles in early disease. Biochem Med 2:364–371Google Scholar
  285. Peter JB, Worsfold M, Pearson CM (1969) Erythrocyte ghost adenosine triphosphatase in Duchenne dystrophy. J Lab Clin Med 74:103–108Google Scholar
  286. Peter JB, Fiehn W, Nagamoto T, Andiman R, Stempel K, Bowman R (1974) Studies of sarcolemma from normal and diseased skeletal muscle. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy II. Amsterdam, Excerpta Medica, pp 479–490Google Scholar
  287. Pfändler U (1950) Eine einfach rezessive Form der Dystrophia musculorum progressiva mit einer Sippenstammtafel aus dem Emmental (Schweiz). Dtsch Med Wschr 75:1221–1225Google Scholar
  288. Pickard NA, Gruemer HD, Verrill HL, Isaacs ER, Robinow M, Nance WE, Myers EC, Goldsmith B (1978) Systemic membrane defect in the proximal muscular dystrophies. N Engl J Med 299:841–846Google Scholar
  289. Pirro R, Lauro R, Testa I, Ferretti G, De Martinis C, Dellantonio R (1982) Decreased insulin receptors but normal glucose metabolism in Duchenne muscular dystrophy. Science 216:311–313Google Scholar
  290. Price R (1763) An essay towards solving a problem in the doctrine of chances. By the late Rev. Mr. Bayes. F.R.S. Philos Trans R Soc Lond 53:370–375Google Scholar
  291. Prot J (1971) Genetic-epidemiologic studies in progressive muscular dystrophy. J Med Genet 8:90–96Google Scholar
  292. Prosser EJ, Murphy EG, Thompson MW (1969) Intelligence and the gene for Duchenne muscular dystrophy. Arch Dis Child 44:221–230Google Scholar
  293. Proudfoot NJ, Maniatis T (1980) The structure of human α-globin pseudogene and its relationship to α-globin gene duplication. Cell 21:537–544Google Scholar
  294. Radu H, Stenzel K (1969) Beiträge zum Studium der pseudohypertrophischen Muskeldystrophien. II. Pseudohypertrophische Muskeldystrophie bei Mädchen. Dtsch Z Nervenheilk 196:116–135Google Scholar
  295. Radu H, Migea S, Tötök A, Bordeianu L, Radu A (1968) Carrier detection in X-linked Duchenne type muscular dystrophy. Pluridimensional investigation. J Neurol Sci 6:289–300Google Scholar
  296. Rao GA, Siler K, Larkin EC (1978) Palmitoleic acid in erythrocytes from carriers of Duchenne muscular dystrophy. Science 200:1416Google Scholar
  297. Ratnoff O, Jones PK (1977) The laboratory diagnosis of the carrier state for classic hemophilia. Ann Int Med 86:521–528Google Scholar
  298. Ritossa FM, Atwood KC, Spiegleman S (1966) A molecular explanation of the bobbed mutants of Drosophila as partial deficiencies of ribosomal DNA. Genetics 54:819–834Google Scholar
  299. Robinson L (1979) Split genes and muscular dystrophy. Muscle and Nerve 2:458–464Google Scholar
  300. Rodan GA, Rodan SB, Raible DG, Cutler LS, Wacholtz M, Sha'ari RI (1979) Adenylate cyclase in muscular dystrophy. Ann NY Acad Sci 317:670–691Google Scholar
  301. Rodemann HP (1979) Die molekularen Mechanismen des pathophysiologischen Alterns: Untersuchungen an Hautfibroblasten von Patienten mit Duchenne-Muskeldystrophie. Dissertation, Stuttgart-HohenheimGoogle Scholar
  302. Rosenmann E, Kreis C, Thompson RG, Dobbs M, Hamerton JL, Wrogeman K (1982) Analysis of fibroblast proteins from patients with Duchenne muscular dystrophy by two-dimensional gel electrophoresis. Nature 298:563–565Google Scholar
  303. Roses AD (1979) Erythrocyte membranes autophosphorylation in Duchenne muscular dystrophy: effect of two methods of ghost preparation on results. Clin Chim Acta 95:69–74Google Scholar
  304. Roses AD, Appel SH (1976) Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy. J Neurol Sci 29:185–193Google Scholar
  305. Roses AD, Herbstreith M, Metcalf B, Appel SH (1976a) Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne dystrophy. J Neurol Sci 30:167–178Google Scholar
  306. Roses AD, Roses MJ, Miller SE, Hull KL, Appel SH (1976b) Carrier detection in Duchenne muscular dystrophy. N Engl J Med 294:193–198Google Scholar
  307. Roses AD, Roses MJ, Metcalf BS, Hull KL, Nicholson GA, Hartwig GB, Roe CR (1977) Pedigree testing in Duchenne muscular dystrophy. Ann Neurol 2:271–278Google Scholar
  308. Roses AD, Hartwig GB, Mabry M, Nagano Y, Miller SE (1980) Red blood cell and fibroblast membranes in Duchenne and myotonic muscular dystrophy. Muscle and Nerve 3:36–54Google Scholar
  309. Roses AD, Shile PE, Herbstreith MH, Balakrishnan CV (1981) Identification of abnormally (32P)-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy. Neurology 31:1026–1030Google Scholar
  310. Roses MS, Nicholson MT, Kircher CS, Roses AD (1977) Evaluation and detection of Duchenne's and Becker's muscular dystrophy carriers by manual muscle testing. Neurology 27:20–25Google Scholar
  311. Rott HD, Mulz D (1982) Muskeldystrophie Duchenne: Konduktorinnenerfassung mit Ultraschall. Dtsch med Wschr 107:1678–1681Google Scholar
  312. Rott HD, Mulz D (1983) Duchenne's muscular dystrophy: Carrier detection by muscle ultrasound. J Génét Hum 31:63–65Google Scholar
  313. Rowland LP (1976) pathogenesis of muscular dystrophies. Arch Neurol 33:315–321Google Scholar
  314. Rowland LP (1980) Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle and Nerve 3:3–20Google Scholar
  315. Rowland LP, Osnos M, Hirschberg E (1960) Serum enzymes in the myopathies. Trans Am Neurol Assoc 85:15–18Google Scholar
  316. Roy S, Dubowitz V (1970) Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes. J Neurol Sci 11:65–79Google Scholar
  317. Ruitenbeek W (1978a) The fatty acid composition of various lipid fractions isolated from erythrocytes and blood plasma of patients with Duchenne and congenital myotonic muscular dystrophy.Clin Chim Acta 89:99–110Google Scholar
  318. Ruitenbeek W (1979) Membrane-bound enzymes of erythrocytes in human muscular dystrophy: (Na++K+)-ATPase, Ca++-ATPase, K+- and Ca++-p-nitrophenylphosphatase. J Neurol Sci 41:71–80Google Scholar
  319. Ruitenbeek W, Edixhoven MJ, Scholte HR (1978b) Osmotic stability of erythrocytes in human muscular dystrophy before and after phospholipase treatment. Clin Chim Acta 94:259–266Google Scholar
  320. Sage J, Inati Y, Samaha F (1979) The importance of serum pyruvate kinase in neuromuscular diseases and carrier states. Muscle and Nerve 2:390–393Google Scholar
  321. Samaha FJ (1972) Tropomyosin and troponin in normal and dystrophic human muscle. Arch Neurol 26:547–550Google Scholar
  322. Samaha FJ, Gergely J (1969) Biochemical abnormalities of the sarcoplasmic reticulum in muscular dystrophy. N Engl J Med 280:184–188Google Scholar
  323. Samaha FJ, Congedo CZ (1977) Two biochemical types of Duchenne dystrophy: sarcoplasmic reticulum membrane proteins. Ann Neurol 1:125–130Google Scholar
  324. Samaha FJ, Thies WH (1979) Myosin light chains in Duchenne dystrophy and paraplegic muscle. Neurology 29:122–125Google Scholar
  325. Sands ME, Harris R (1979) Lymphocyte capping and carrier detection rate in Duchenne muscular dystrophy. Lancet ii:698Google Scholar
  326. Sanyl SK, Johnson WW (1982) Cardiac conduction abnormalities in children with Duchenne's progressive muscular dystrophy: Electrocardiographic features and morphologic correlates. Circulation 66:853–863Google Scholar
  327. Satapathy RK, Skinner R (1979) Serum creatine kinase levels in normal females. J Med Genet 16:49–51Google Scholar
  328. Sato B, Nishikida K, Samuels LT, Tyler FH (1978) Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. J Clin Invest 61:251–259Google Scholar
  329. Scarlato G, Meola G, Silani V, Manfredi L, Bottiroli G, Zanella A (1979) Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers. A new approach to carrier detection. Acta Neurol Scand 59:262–269Google Scholar
  330. Scarpalezos S, Panayiotopoulos CP (1973) Duchenne muscular dystrophy: Reservations to the neurogenic hypothesis. Lancet ii:458Google Scholar
  331. Shay JW, Cook J, Fuseler JW (1979a) Microtubules and Duchenne muscular dystrophy. Ann Neurol 6:147Google Scholar
  332. Shay JW, Fuseler JW (1979b) Diminished microtubules in fibroblast cells derived from inherited dystrophic muscle explants. Nature 278:178–180Google Scholar
  333. Shoji S (1981) Calcium flux of erythrocytes in Duchenne muscular dystrophy. J Neurol Sci 51:427–435Google Scholar
  334. Sica REP, McComas AJ (1978) The neural hypothesis of muscular dystrophy. A review of recent experimental evidence with particular reference to the Duchenne form. Can J Neurol Sci 5:189–197Google Scholar
  335. Siddiqui QR, Pennington RJT (1977) Effect of ouabain upon erythrocyte membrane adenosine triphosphatase in Duchenne muscular dystrophy. J Neurol Sci 34:365–372Google Scholar
  336. Silverman LM, Gruemer HD (1976) Sarcolemmal membrane changes related to enzyme release in the imipramine/serotonin experimental animal model. Clin Chem 22:1710–1714Google Scholar
  337. Skinner R, Smith C, Emery AEH (1974) Linkage between the loci for benign (Becker-type) X-borne muscular dystrophy and deutan colour blindness. J Med Genet 11:317–320Google Scholar
  338. Skinner R, Emery AEH, Scheuerbrandt G, Syme J (1982) Feasibility of neonatal screening for Duchenne muscular dystrophy. J Med Genet 19:1–3Google Scholar
  339. Skyring A, McKusick V (1961) Clinical, genetic and electrocardiographic studies in childhood muscular dystrophy. Am J Med Sci 242:534–547Google Scholar
  340. Slightom JL, Blechl AE, Smithies O (1980) Human fetal Gγ- and Aγ-globin genes: Complete nucleotide sequences suggest that DNA can be exchanged between these duplicated genes. Cell 21:627–638Google Scholar
  341. Smith CAB, Kilpatrick SJ (1958) Estimates of the sex ratio of mutation rates in sex-linked conditions by the method of maximum likelihood. Ann Hum Genet 22:244–249Google Scholar
  342. Smith I, Elton RA, Thomson WHS (1979) Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: Serum creatine phosphokinase values in premenarchal menstruating, postmenopausal and pregnant normal women. Clin Chim Acta 98:207–216Google Scholar
  343. Soltan HC (1977) Echinocytes in families with Duchenne dystrophy. J Med Genet 14:276–278Google Scholar
  344. Somer H, Olarte M (1977) Red blood cells in Duchenne muscular dystrophy: increased osmotic fragility, lack of increased enzyme leakage. Neurology 27:361Google Scholar
  345. Somer H, Chien S, Sung LA, Thurn A (1979) Erythrocytes in Duchenne dystrophy: osmotic fragility and membrane deformability. Neurology 29:519–522Google Scholar
  346. Souweine G, Bernard JC, Lasne Y, Lachanat J (1978) The sodium pump of erythrocytes from patients with Duchenne muscular dystrophy: effects of ouabain on the active sodium flux and on (Na+, K+)ATPase. J Neurol 217:287–294Google Scholar
  347. Spiegler A, Wiedemann G, Herrmann FH, Menzel K, Hoffmann W (1982) Altersabhängigkeit der Creatinkinase-(CK-) Aktivität im Serum: Referenzwerte zur Konduktorinnendiagnostik bei Duchenne-Muskeldystrophie (DMD). Dtsch Gesundheitswesen 37:2009–2013Google Scholar
  348. Spowart G, Buckton KE, Skinner R, Emery AEH (1982) X-chromosome in Duchenne muscular dystrophy. Lancet i:1251Google Scholar
  349. Sugita H, Tyler FH (1963) Pathogenesis of muscular dystrophy. Trans Assoc Am Physicians 76:231–244Google Scholar
  350. Sugita H, Okimoto K, Ebashi S, Okinaka S (1967) Biochemical alterations in progressive muscular dystrophy with special reference to the sarcoplasmic reticulum. In: Milhorat AT (ed) Exploratory concepts in muscular dystrophy and related disorders. Amsterdam, Excerpta Medica Foundation, p 321Google Scholar
  351. Susheela AK, Kaul RD, Sachdev K, Singh N (1975) Adenyl cyclase activity in Duchenne dystrophic muscle. J Neurol Sci 24:361–363Google Scholar
  352. Sybert VP, Setran KN, Kadin ME (1979) Lymphocyte capping in carriers of Duchenne muscular dystrophy. N Engl J Med 301:724–725Google Scholar
  353. Schapira G, Dreyfus JC, Schapira F (1953) L'élévation du taux de l'aldolase sérique: test biochimique de myopathies. Sem Hôp Paris 29:1917–1921Google Scholar
  354. Schmalbruch H (1975) Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol 33:129–141Google Scholar
  355. Schmalbruch H (1979) A freeze-fracture study of the plasma membrane of muscle fibers of a patient with chronic creatine kinase elevation suspected for malignant hyperthermia. J Neuropathol Exp Neurol 38:407–418Google Scholar
  356. Scholte HR, Busch HMF (1979) 5′-nucleotidase activity in Duchenne muscular dystrophy. N Engl J Med 301:726Google Scholar
  357. Scholte HR, Busch HFM (1980) Decreased phosphorylase activity in leucocytes of Duchenne carriers. Clin Chim Acta 105:137–139Google Scholar
  358. Schotland DL, Bonilla E, Wakayama Y (1981) Freeze-fracture studies of muscle plasma membrane in human muscular dystrophy. Acta Neuropathol 54:189–197Google Scholar
  359. Statham HE, Witkowsky JA, Dubowitz V (1979) Protein degradation in skin fibroblasts from patients with Duchenne muscular dystrophy. Biochem J 192:257–262Google Scholar
  360. Statham HE, Dubowitz V (1979) Duchenne muscular dystrophy: 45Ca exchange in cultured skin fibroblasts and the effect of calcium ionophore A 23187. Clin Chim Acta 96:225–231Google Scholar
  361. Stengel-Rutkowski L, Scheuerbrandt G, Beckmann R, Pongratz D (1977) Prenatal diagnosis of Duchenne's muscular dystrophy. Lancet i:1359–1360Google Scholar
  362. Stephens FE, Tyler FH (1951) Studies in disorders of muscle. V. The inheritance of childhood progressive muscular dystrophy in 33 kindreds Am J Hum Genet 3:111–125Google Scholar
  363. Stephens J, Lewin E (1965) Serum enzyme variations and histological abnormalities in the carrier state in Duchenne dystrophy. J Neurol Neurosurg Psychiatry 28:104–108Google Scholar
  364. Stern LM (1972) Four cases of Duchenne-type muscular dystrophy in girls. Med J Aust 2:1066–1069Google Scholar
  365. Stern CMM, Kahan MC, Dubowitz V (1979) Lymphocyte capping in Duchenne muscular dystrophy. Lancet i:1300Google Scholar
  366. Stevenson AC (1958) Muscular dystrophy in Northern Ireland. IV. Some additional data. Ann Hum Genet 22:231–234Google Scholar
  367. Takagi A, Schotland DL, Rowland LP (1973) Sarcoplasmic reticulum in Duchenne dystrophy. Arch Neurol 28:380–384Google Scholar
  368. Takahashi K, Takao H, Takai T (1978) Adenylate cyclase in Duchenne and Fukuyama type muscular dystrophy. Kobe J Med Sci 24:193–198Google Scholar
  369. Tartof KD (1975) Redundant genes. Ann Rev Genet 9:355–385Google Scholar
  370. Ten Kate LP, Offringa PJ (1981) The significance of different types of information in calculating the probability that a female relative of a Duchenne muscular dystrophy patient is a carrier. Clin Genet 20:281–288Google Scholar
  371. Testard R, Mendolia M, Larget-Piet L, Williamson C, Delaitre R (1973) A propos d'une myopathie de Duchenne de Boulogne chez une fille. Ouest Méd Paris 26:1175–1178Google Scholar
  372. Thompson CE (1978) Reproduction in Duchenne dystrophy. Neurology 28:1045–1047Google Scholar
  373. Thompson RG, Sponder ES, Rosenmann E, Hamerton JL, Wrogeman K (1982) Proline incorporation by cultured skin fibroblasts from patients with Duchenne muscular dystrophy. J Neurol Sci 57:41–54Google Scholar
  374. Thomson WHS (1969) The biochemical identification of the carrier state in X-linked recessive (Duchenne) muscular dystrophy. Clin Chim Acta 26:207–221Google Scholar
  375. Thomson WHS (1979) Carrier-detection rate and age in Duchenne muscular dystrophy. Lancet i:829Google Scholar
  376. Thomson WHS, Sweeting JC, Hamilton IJD (1975) ATP and muscle enzyme efflux after physical exertion. Clin Chim Acta 59:241–245Google Scholar
  377. Tomkins JK (1980) The molecular defect in Duchenne muscular dystrophy. Muscle and Nerve 3:529–530Google Scholar
  378. Tomlinson BE, Walton JN, Irving D (1974) Spinal cord limb motor neurones in muscular dystrophy. J Neurol Sci 22:305–327Google Scholar
  379. Tzvetanova E (1971) Aldolase isoenzymes in serum and muscle from patients with progressive muscular dystrophy and from human foetus. J Neurol Sci 14:483–489Google Scholar
  380. Valli G, Scarlato G, Contartese M (1976) Quantitative electromyography in the detection of the carriers in Duchenne type muscular dystrophy. J Neurol 212:139–149Google Scholar
  381. Vasiljevic ZM, Polic DD (1983) Morphological changes of erythrocytes in patients and carriers of Duchenne disease. Acta Neurol Scand 67:242–244Google Scholar
  382. Vassella F, Richterich R, Rossi E (1965) The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Pediatrics 35:322–330Google Scholar
  383. Verellen C, Freund M, DeMeyer R, Laterre C, Scholberg B, Frédéric J (1977) Progressive muscular dystrophy of the Duchenne type in a young girl associated with an aberration of chromosome X. Excerpta Medica Int Congr Ser 426, p 42Google Scholar
  384. Verril HL, Pickard NA, Gruemer HD (1977) Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy. Clin Chem 23:2341–2343Google Scholar
  385. Vickers JD, McComas AJ, Rathbone MP (1978) Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy. Can J Neurol Sci 5:437–442Google Scholar
  386. Vignos PJ, Farah M, Evans E (1978) Affection cardiaque dans la dystrophie musculaire de Duchenne. Une étude échocardiographique préliminaire et clinique. Cahiers Rééd Réadapt 13:277–283Google Scholar
  387. Vogel F (1955) Vergleichende Betrachtungen über die Mutationsrate der geschlechtsgebunden-rezessiven Hämophilieformen in der Schweiz und Dänemark. Blut 1:91–109Google Scholar
  388. Vogel F (1956) Über die Prüfung von Modellvorstellungen zur spontanen Mutabilität an menschlichem Material. Z Menschl Vererb Konstitutionsl 33:470–491Google Scholar
  389. Vogel F (1958) Gedanken über den Mechanismus einiger spontanen Mutationen beim Menschen. Z Menschl Vererb Konstitutionsl 34:389–399Google Scholar
  390. Vogel F (1965) Sind die Mutationsraten für die X-chromosomal recessiven Haemophilieformen in Keimzellen von Frauen niedriger als in Keimzellen von Männern? Humangenetik 1:253–263Google Scholar
  391. Vogel F (1977) A probable sex difference in some mutation rates. Am J Hum Genet 29:312–319Google Scholar
  392. Vogel F, Rathenberg R (1975) Spontaneous mutations in man. In: Harris H, Hirschhorn K (eds) Advances in human genetics, vol 5. Plenum Press, New York LondonGoogle Scholar
  393. Vogel F, Motulsky AG (1979) Human genetics. Problems and approaches. Springer, Berlin Heidelberg New YorkGoogle Scholar
  394. Wacholtz MC, Raible DG, Jackowski S, Rodan SB, Rodan GA, Sha'afi RI (1979) Adenylate cyclase and ATPase activities in red cell membranes of patients and genetic carriers of Duchenne muscular dystrophy. Clin Chim Acta 96:255–259Google Scholar
  395. Walton JN (1955) On the inheritance of muscular dystrophy. Ann Hum Genet 20:1–38Google Scholar
  396. Walton JN (1957) The inheritance of muscular dystrophy. Acta Genet Stat Med 7:318–320Google Scholar
  397. Walton JN, Gardner-Medwin D (1981) Progressive muscular dystrophy and the myotonic disorders. In: Walton JN (ed) Disorders of voluntary muscle, 4th ed. Churchill Livingstone, Edinburgh London Melbourne New York, pp 481–524Google Scholar
  398. Wassner SJ, Li JB, Ladda RL, Lorenz RP, Emery AEH (1982) Prenatal diagnosis of Duchenne muscular dystrophy: Failure of amniotic fluid and maternal serum NT-methylhistidine analyses to detect affected fetuses. Am J Obstet Gynecol 143:216–219Google Scholar
  399. Wertz RL, Roses AD (1982) Letter to the editor: premature aging of fibroblasts from patients with Duchenne muscular dystrophy. Pediatr Res 16:589–590Google Scholar
  400. Wieacker P, Davies K, Pearson P, Ropers HH (1983) Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences. Lancet i:1325–1326Google Scholar
  401. Wilkerson LS, Perkins RC, Roelofs R, Swift L, Dalton LR, Park JH (1978) Erythrocyte membrane abnormalities in Duchenne muscular dystrophy monitored by saturation transfer electron paramagetic resonance spectroscopy. Proc Natl Acad Sci USA 75:838–841Google Scholar
  402. Wilson KM, Evans KA, Carter CO (1965) Creatine kinase levels in women who carry genes for three types of muscular dystrophy. Br Med J 1:750–753Google Scholar
  403. Williams WR, Thompson MW, Morton NE (1983) Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy. Am J Med Genet 14:315–333Google Scholar
  404. Winter RM (1980) Estimation of male to female ratio of mutation rates from carrier-detection tests in X-linked disorders. Am J Hum Genet 32:582–588Google Scholar
  405. Winter RM, Pembrey ME (1982) Does unequal crossing over contribute to the mutation rate in Duchenne muscular dystrophy? Am J Med Genet 12:437–441Google Scholar
  406. Wood DS, Sorenson M, Eastwood AB, Charash WE, Reuben JP (1978) Duchenne dystrophy: abnormal generation of tension and Ca++ regulation in single skinned fibers. Neurology 28:447–457Google Scholar
  407. Worden DK, Vignos PJ Jr (1962) Intllectual function in childhood progressive muscular dystrophy. Pediatrics 29:968–977Google Scholar
  408. Wrogeman K, Pena SDJ (1976) Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet i:672–673Google Scholar
  409. Wyatt PR, Cox DM (1977) Duchenne's muscular dystrophy: Studies in cultured fibroblasts. Lancet i:172–174Google Scholar
  410. Yasmineh WG, Ibrahim GA, Abbasnezhad M, Awad EA (1978) Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders. Clin Chem 24:1985–1988Google Scholar
  411. Yasuda N, Kondo K (1980) No sex difference in mutation rates of Duchenne muscular dystrophy. J Med Genet 17:106–111Google Scholar
  412. Yasuda N, Kondo K (1982) The effect of parental age on rate of mutation for Duchenne muscular dystrophy. Am J Med Genet 13:91–99Google Scholar
  413. Yoshioka M, Okuda R (1977) Human skeletal muscle fibers in normal and pathological states. Freeze-etch replica observations. J Electron Microsc 26:103–110Google Scholar
  414. Yoshioka M (1981) Clinically manifesting carriers in Duchenne muscular dystrophy. Clin Genet 20:6–12Google Scholar
  415. Zatz M, Otto PA (1980) Effect of age on the detection rate in Duchenne muscular dystrophy. J Neurol Sci 47:407–410Google Scholar
  416. Zatz M (1983) Effect of genetic counseling on Duchenne muscular dystrophy families in Brazil. Am J Med Genet 15:483–490Google Scholar
  417. Zatz M, Frota-Pessoa O, Peres CA (1975) Use of normal daughters' CPK levels in the estimation of heterozygosity risks in X-linked muscular dystrophies. Hum Hered 25:354–359Google Scholar
  418. Zatz M, Frota-Pessoa A, Levy JA, Peres CA (1976) Creatine phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: A Brazilian study. J Génét Hum 24:153–168Google Scholar
  419. Zatz M, Shapiro LJ, Campion DS, Kaback MM, Otto PA (1980) Serum pyruvatekinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker). J Neurol Sci 46:267–279Google Scholar
  420. Zatz M, Vianna-Morgante AM, Campos P, Diament AJ (1981) Translocation (X;6) in a female with Duchenne muscular dystrophy: implications for the localization of the DMD locus. J Med Genet 18:442–447Google Scholar
  421. Zatz M, Karp LE, Rogatka A (1982) Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD). Am J Med Genet 13:257–262Google Scholar
  422. Zatz M, Passos MR, Bortolini ER (1983) Letter to the editor: Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy. Am J Med Genet 15:149–151Google Scholar
  423. Zellweger H, Niedermeyer E (1965) Central nervous system manifestations in childhood muscular dystrophy. I. Psychometric and electroencephalographic findings. Ann Paediatr 205:25–42Google Scholar
  424. Zellweger H, Hanson JW (1968) Psychometric studies in muscular dystrophy type IIIa (Duchenne). Dev Med Child Neurol 9:576–581Google Scholar
  425. Zellweger H, Antonik A (1975) Newborn screening for Duchenne muscular dystrophys. Pediatrics 55:30–34Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • H. Moser
    • 1
  1. 1.Genetic Counselling ServiceUniversity Department of Pediatrics, InselspitalBerneSwitzerland

Personalised recommendations